Betaseron (Interferon beta-1b, BAY86-5046)

DRUG2 trials

Sponsors

Bayer

Conditions

Multiple SclerosisRelapsing-Remitting

Phase 2

BEYOND Pilot Study

CompletedNCT00893217

BayerMultiple Sclerosis, Relapsing-Remitting

Start: 2002-11-30End: 2003-06-30Updated: 2009-11-09

Unknown Phase

Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.

CompletedNCT01031459

BayerMultiple Sclerosis

Start: 2010-01-31End: 2010-12-31Updated: 2012-01-05